Singleron Biotechnologies is an innovative and fast-growing company that offers complete solutions for single-cell sequencing technologies. Singleron provides clinicians and researchers with breakthrough single-cell analysis techniques to improve clinical diagnosis, drug development, and health management. The company was founded in January 2018 and currently has offices, laboratories and manufacturing facilities in Cologne, Germany, Nanjing and Suzhou in China, and New Haven, CT, USA.